Skip to main content
Log in

Selective neonatal BCG vax − a cost-effective option in Ireland?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Bacillus Calmette-Guérin

Reference

  • Teljeur C, et al. Economic Evaluation of Selective Neonatal BCG Vaccination of High-Risk Infants in Ireland. Pediatric Infectious Disease Journal : 9 Feb 2018. Available from: URL: http://doi.org/10.1097/INF.0000000000001891

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selective neonatal BCG vax − a cost-effective option in Ireland?. PharmacoEcon Outcomes News 797, 29 (2018). https://doi.org/10.1007/s40274-018-4738-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4738-0

Navigation